I was recently asked by my friends at Darling Hemp to participate in a video they created to highlight some of the most important issues that the Rule raises.
Considering the large and growing number of hemp and CBD companies doing business in the US right now, the companies that received warning letters might rightly consider themselves unlucky.
As the cannabis industry matures, insurance is becoming a major factor in its growth and normalization. In many respects, the development and availability of insurance products signals a new phase in the industry.
As a cannabis attorney, one of the questions I am asked most frequently is whether hemp and hemp products can be transported across state lines.
Failing to establish testing uniformity almost guarantees mayhem as buyers and growers attempt to create an interstate market for hemp because of the uncertainty a buyer in one state faces when attempting to import hemp from another state.
It is clear is that the FTC has fully entered the CBD regulatory space and we can expect to hear more from it during the coming months.
Jobs in the legal cannabis industry are coming by the hundreds of thousands and there’s no sign of that halting.
The “wild west” days of manufacturing and selling cannabis products outside the sphere of regulatory influence are rapidly coming to an end.
There is really no portion of American life that the Hemp for Victory bill does not touch. It seeks to study the potential uses of hemp across all sectors of our economy.
Regardless of how the FDA will eventually regulate CBD, it is abundantly clear that CBD companies should not make medical/disease claims nor market their products as dietary supplements. Doing so at this point is simply foolish.